Compare Prima Cakrawala Abadi Tbk. (PCAR) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Prima Cakrawala Abadi Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Prima Cakrawala Abadi Tbk. trades at Rp43 (market cap 51.33B, 1.56M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Organon Pharma Indonesia Tbk. is far larger — about 2× Prima Cakrawala Abadi Tbk.'s market cap. Which is the better fit depends on your goals.
| PCAR | SCPI | |
|---|---|---|
Market Cap | 51.33B | 104.4B |
Volume | 1.56M | — |
Lot | 15.58K | — |
Turnover | 66.98M | — |
Average Price | 43 | — |
Value | 66.98M | — |
Indicative Equilibrium Price | 43 | — |
Indicative Equilibrium Volume | 1.03K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Prima Cakrawala Abadi Tbk.
The Company was established with the name of PT Prima Abadi is a limited company that was established based on the deed of establishment Limited Company PT Prima Cakrawala Abadi No. 111 issued on January 29 2014. The Articles of Association of the company has been experiencing some changes, the updated was the Decision of the Shareholders No. 20 issued on September 19, 2017. The company started commercial business activities in the year 2014.
Read more on PCAR →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
